Login to Your Account



Panel: Rate of M&A to continue; value unlikely to top 2014 numbers

By Jennifer Boggs
Managing Editor

Monday, February 9, 2015

NEW YORK – The banner year for biopharma M&A that characterized 2014 – a total of 364 deals for a whopping value of $215 billion – is unlikely to be repeated, at least in terms of value, but the rate of dealmaking is expected to continue.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription